Abara onye nyocha ọbara na ahịa reagent ọnụ ahịa na $ 3,654.18 nde na 2018 ma na-atụ anya iru $ 6,344,230 site na 2025, yana ọnụego uto kwa afọ nke 8.20% n'oge amụma.
Hematology bụ ngalaba nke ọgwụ na-agụnye ọmụmụ ihe, nchọpụta, ọgwụgwọ na atụmanya nke ọrịa ndị metụtara ọbara.Enwere ike iji ndị na-enyocha ọbara ọbara na ndị na-eme ihe na-achọpụta ọrịa dị iche iche metụtara mkpụrụ ndụ ọbara uhie, mkpụrụ ndụ ọbara ọcha, platelet, na ụmị ọkpụkpụ, na protein na-etinye aka na ọbara ọgbụgba na coagulation.Ọ nwekwara ike ịhazi ọkwa ọgwụ plasma nke ọgwụ ọgwụgwọ na ọgwụ na-akwadoghị.
E kewara onye nyocha hematology zuru ụwa ọnụ na akụkọ ahịa reagent site na ngwaahịa, ngwa, onye ọrụ njedebe, yana ọkwa mpaghara na mba.Dabere na ngwaahịa ahụ, enwere ike kewaa onye nyocha ọbara ọbara zuru ụwa ọnụ na ahịa reagent n'ime ndị na-enyocha ọbara, ndị na-enyocha hemostatic, ndị na-enyocha protein plasma, ndị na-enyocha haemoglobin, ndị na-enyocha ọnụ ọgụgụ sedimentation erythrocyte, ndị na-enyocha coagulation, cytometers na-asọpụta, ndị na-eme ihe nkiri slide, counterdị iche iche na ntụpọ ọbara.Dị ka ngwa ahụ si kwuo, enwere ike kewaa onye nyocha ọbara na ahịa reagent n'ime anaemia, ọrịa kansa ọbara, ọrịa na-agba ọbara, ọrịa metụtara ọrịa, ọrịa ndị metụtara sistemu sistemu, wdg dabere na ndị ọrụ njedebe, a na-ekewa ndị na-enyocha hematology zuru ụwa ọnụ na ahịa reagent. banye n'ụlọ ọgwụ, ndị na-enye ọrụ azụmahịa, ụlọ nyocha nyocha, na ụlọ ọrụ nyocha na agụmakwụkwọ.
Mpaghara ndị nyocha ọbara a na akụkọ reagent kpuchiri bụ North America, Europe, Asia Pacific na mpaghara ndị ọzọ nke ụwa.Dị ka mba larịị, ahịa maka ọbara analyzer na reagents nwere ike kewaa n'ime United States, Mexico, Canada, United Kingdom, France, Germany, Italy, China, Japan, India, Southeast Asia, Middle East (UAE,) Saudi Arabia), na Egypt, Africa, wdg.
Sysmex, Danaher, Nihon Kohden, Siemens, Abbott Laboratories, Boule Diagnostics, HORIBA Bio-Rad Laboratories, BioSystems, Diatron, Drew Scientific, EKF Diagnostics, Mindray, Ortho Clinical Diagnostics, Roche na ndị ọzọ.
Mmụba nke ọrịa ọbara na onyinye ọbara bụ isi ihe na-ebute uto nke ahịa ngwaahịa hematology zuru ụwa ọnụ.Agbanyeghị, ọnụ ahịa nhazi mbụ dị elu na gburugburu usoro iwu siri ike bụ ụfọdụ ihe na-egbochi uto ahịa.Dịka ọmụmaatụ, Abbott Diagnostics webatara onye nyocha ọbara CELL-DYN Ruby*, nke na-efu ihe dịka US$185,000.Na mgbakwunye, ihe ndị dị ka ọganihu teknụzụ na ndị na-enyocha ọbara na reagents, ngwakọta nke teknụzụ cytometry eruba na ndị na-enyocha ọbara, na njikọta na nnweta nwere ike inye ohere uto maka ahịa ahụ.Dịka ọmụmaatụ, na 2012, Transasia nwetara IAS Diagnostics, na Bio-Rad webatara Liquichek hematology na teknụzụ njikwa reticulocyte.
A na-ekewa ihe nyocha ọbara ọbara zuru ụwa ọnụ na ahịa reagent n'ime North America, Europe, Asia Pacific na the rest of the World (ROW).N'ihi mmụba nke ọrịa kansa na anaemia, mmepe nke ụlọ ọrụ ahụike yana mmụba nke ọnụ ọgụgụ ụlọ ọgwụ nyocha dị elu, North America bụ isi ihe na-enye aka na ahịa a, nke bụ ụfọdụ ihe na-ebute uto ahịa na mpaghara a.Dị ka American Cancer Society si kwuo, lymphoma na-abụghị Hodgkin bụ otu n'ime ụdị ọrịa cancer na-emekarị na United States, na-aza 4% nke ọrịa cancer niile.A na-eme atụmatụ na a ga-eme nchọpụta 74,680 na United States na 2018. 70% nke ndị a chọpụtara na ha nwere lymphoma na-abụghị Hodgkin na-ebi ma ọ dịkarịa ala afọ 5 mgbe a chọpụtachara ya.Ọrịa ọbara ndị dị otú ahụ ga-akwalite uto ahịa.N'ihi ohere etinyeghị ya, ọkachasị na akụ na ụba na-emepe emepe dị ka India na China, a na-atụ anya na mpaghara Eshia-Pacific ga-enweta uto bara uru n'oge amụma.
Nweta akụkọ zuru ezu: @ https://brandessenceresearch.com/healthcare/hematology-analyzer-and-reagent-market
Akụkọ metụtara: @ https://bmrc-shubham.medium.com/chatbot-market-professional-survey-report-2021-dace5adb1283
https://bmrc-shubham.medium.com/heavy-duty-truck-market-industry-research-share-trend-2021-d45d2570db28
Oge nzipu: Feb-19-2021